Shares of Abbott Laboratories ABT rose 2.29% to $132.06 Wednesday, on what proved to be an all-around positive trading ...

Bernstein analyst Lee Hambright raised the firm’s price target on Abbott (ABT) to $138 from $135 and keeps an Outperform rating on the shares ...

Abbott Laboratories (NYSE:ABT) reported its Q3 2024 earnings, meeting EPS expectations while slightly missing revenue forecasts. The company posted an EPS of $1.34, aligning with analysts' predictions ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a ...

Abbott Laboratories (ABT) reported weaker-than-expected fourth quarter sales due to weakness in its nutrition and diagnostics units. The company's full-year outlook met estimates as medical device ...

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to offset a hit ...

(Reuters) - Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated medtech-related procedures to boost demand for its devices, including ...

At Holdings Channel, we have reviewed the latest batch of the 26 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Abbott Laboratories (Symbol: ABT) was held by 19 of ...

AUSTIN, Texas, Jan. 21, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced that it plans to release ...